Phospholipid oxidation generates potent anti‐inflammatory lipid mediators that mimic structurally related pro‐resolving eicosanoids by activating Nrf2
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Exposure of biological membranes to reactive oxygen species creates a complex mixture of distinct oxidized phospholipid (Ox PL ) species, which contribute to the development of chronic inflammatory diseases and metabolic disorders. While the ability of Ox PL to modulate biological processes is increasingly recognized, the nature of the biologically active Ox PL species and the molecular mechanisms underlying their signaling remain largely unknown. We have employed a combination of mass spectrometry, synthetic chemistry, and immunobiology approaches to characterize the Ox PL generated from the abundant phospholipid 1‐palmitoyl‐2‐arachidonoyl‐ sn ‐glycero‐3‐phosphocholine ( PAPC ) and investigated their bioactivities and signaling pathways in vitro and in vivo . Our study defines epoxycyclopentenones as potent anti‐inflammatory lipid mediators that mimic the signaling of endogenous, pro‐resolving prostanoids by activating the transcription factor nuclear factor E2‐related factor 2 (Nrf2). Using a library of Ox PL variants, we identified a synthetic Ox PL derivative, which alleviated endotoxin‐induced lung injury and inhibited development of pro‐inflammatory T helper (Th) 1 cells. These findings provide a molecular basis for the negative regulation of inflammation by lipid peroxidation products and propose a novel class of highly bioactive compounds for the treatment of inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 3×
“…isoprostanes; lung injury; Nrf2; oxidized phospholipids Subject Categories Immunology; Pharmacology & Drug Discovery DOI 10.15252/emmm.201404702 | Received 1 October 2014 | Revised 15 February 2015 | Accepted 16 February 2015 | Published online 13 March 2015 EMBO Mol Med (2015) 7: 593–607”
InfluentialImai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis
Thimmulappa, R. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25790 · Cited by 1,028 · cited 1×
“This is in line with reports showing enhanced inflammatory responses and increased mortality of Nrf2deficient mice during septic shock (Thimmulappa, 2006).”
Watson, A. D., Leitinger, N., Navab, M., Faull, K. F., Hörkkö, S., Witztum, J. L., Palinski, W., Schwenke, D., Salomon, R. G., Sha, W., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.21.13597 · Cited by 753 · cited 6×
“While the first bioactive OxPL species have been identified and associated with defined biological effects (Watson et al, 1997, 1999; Podrez et al, 2002; Seimon et al, 2010; Zhong et al, 2013), our knowledge on the contribution of such lipid species to the in vivo regulation of inflammation and on…”
InfluentialComplement factor H binds malondialdehyde epitopes and protects from oxidative stress
Weismann, D., Hartvigsen, K., Lauer, N., Bennett, K. L., Scholl, H. P. N., Issa, P. C., Cano, M., Brandstätter, H., Tsimikas, S., Skerka, C., et al. (2011) · Nature · doi:10.1038/nature10449 · Cited by 533 · cited 3×
“Keywords inflammation; isoprostanes; lung injury; Nrf2; oxidized phospholipids Subject Categories Immunology; Pharmacology & Drug Discovery DOI 10.15252/emmm.201404702 | Received 1 October 2014 | Revised 15 February 2015 | Accepted 16 February 2015 | Published online 13 March 2015 EMBO Mol Med (2015) 7: 593–607”
InfluentialItoh, K., Mochizuki, M., Ishii, Y., Ishii, T., Shibata, T., Kawamoto, Y., Kelly, V., Sekizawa, K., Uchida, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.36-45.2004 · Cited by 407
Cited by
Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis
Warnatsch, A., Ioannou, M., Wang, Q., & Papayannopoulos, V. (2015) · Science · doi:10.1126/science.aaa8064 · Cited by 1,270
Dyall, S. C., Balas, L., Bazan, N. G., Brenna, J. T., Chiang, N., da Costa Souza, F., Dalli, J., Durand, T., Galano, J.-M., Lein, P. J., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101165 · Cited by 660
Redox regulation of immunometabolism
Muri, J., & Kopf, M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00478-8 · Cited by 491
Self-citationInnate sensing of oxidation-specific epitopes in health and disease
Binder, C. J., Papac-Milicevic, N., & Witztum, J. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.63 · Cited by 403
Acute and Residual Soccer Match-Related Fatigue: A Systematic Review and Meta-analysis
Silva, J. R., Rumpf, M. C., Hertzog, M., Castagna, C., Farooq, A., Girard, O., & Hader, K. (2018) · Sports Medicine · doi:10.1007/s40279-017-0798-8 · Cited by 403
Metadata
- Authors
- Bretscher, P., Egger, J., Shamshiev, A., Trötzmüller, M., Köfeler, H., Carreira, E. M., Kopf, M., & Freigang, S.
- Venue
- EMBO Molecular Medicine
- Published
- 2015-03-13
- Volume
- 7
- Issue
- 5
- Pages
- 593-607
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W1992648442
- Cited by
- 88
- References
- 7
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phospholipid oxidation generates potent anti‐inflammatory lipid mediators that mimic structurally related pro‐resolving eicosanoids by activating Nrf2. https://app.cochat.ai/papers/10.15252/emmm.201404702
- The paper
- Bretscher, P., Egger, J., Shamshiev, A., Trötzmüller, M., Köfeler, H., Carreira, E. M., Kopf, M., & Freigang, S. (2015). Phospholipid oxidation generates potent anti‐inflammatory lipid mediators that mimic structurally related pro‐resolving eicosanoids by activating Nrf2. EMBO Molecular Medicine. https://doi.org/10.15252/emmm.201404702
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.